mobileMICROMEDEX gives physicians, pharmacists, and other healthcare professionals reliable clinical information to help support and confirm treatment decisions. Clinicians can trust the data i
Focuses primarily on the drugs used for treatment and symptom management for colorectal cancer.
Portable Drug Companion is a comprehensive, authoritative drug reference to chose from over 5,500 entries, with overdose management, Canadian drug names, OTC and herbal remedies. This "Mini-Suite" of
The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy.
Medicine Products:(Date:12/3/2008)...sters feel better mentally, physically, researcher...ews) -- Overweight kids may be able to work out th... A study of sedentary but otherwise healthy 7- to ...and anger issues by taking part in a 10- to 15-wee...ng applied to children across lines such as race, ...
(Date:12/3/2008)...ing less responsible uses, claims, experts say , ...Expensive, sham stem cell therapies are being hawk...t, experts say. , In response, the leading orga...ed guidelines to steer research in the field towar...earch is progressing so rapidly and has sparked a ...
(Date:12/3/2008)...Interleukin-12 is a naturally occurring protein es...mune system. Having either too much or too little ...of many diseases, including some cancers and auto-...matoid arthritis. In turn, modulating interleukin-...itions. , In an effort to create a new and cost-...
(Date:12/3/2008)...tive osteoporosis treatment could soon be a realit... accurately at which point someone needs further d...rranted, has been developed by The National Osteop... relying primarily on Bone Mineral Density (BMD) m... do, their approach takes into account both the ri...
Breaking Medicine News(10 mins):Health News:Bogus Stem Cell Therapies Sold on Internet 2Health News:Bogus Stem Cell Therapies Sold on Internet 3Health News:Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants 2Health News:Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants 3Health News:WHO tool helps target bone treatment 2...the only bird to have shown the H5N1 virus bird fl...ith the infection and health // officials are now ...t a native species. This has calmed fears of a pan...f veterinary officers admitted that they were unaw...
...e given to a condition characterized by a “thick” ...ugh it remains one of the toughest // conditions f...e condition affects women more than men and is pro...e. It may also be seen in patients with type 2 di...
...ed smuggled bird and poultry parts or in whole.// ...ts found bags of duck feet. Also a similar raid at...million packages of chicken meat smuggled from Chi...is increasing evidence that a thriving internation...
...at the University of Alberta people who do not wea...mpared to people who wear them. // In addition Dr.... Research Lab states that young attractive people ...most neglectful child caretakers of all. His conc...
Other Medicine News:Health News:Smuggling could also be a carrier to bird flu spread. 2Health News:Get that wedding ring on if you want to be branded a responsible parent! 2(Date:12/1/2008)...d With ENB-0040 at Children,s Hospital, Health Sci... 1 Enobia Pharma, an emerging Cana...herapeutics for serious bone disorders, today anno...l program for hypophosphatasia was dosed. Enobia i...ith ENB-0040 for the treatment of this rare and of...
(Date:12/1/2008)...ire-FirstCall/ -- Genaera Corporation (Nasdaq: ... begun in study MSI-1436C-102 (Study 102), the mul...ne (MSI-1436) in overweight and obese type 2 diabe...tment of type 2 diabetes and obesity which works c...leptin pathways through the highly selective inhib...
(Date:12/1/2008)... -- GeoVax Labs, Inc.,(OTC Bulletin Board: GOVX),...,human vaccines for diseases caused by HIV-1 (Hum...gents, announced today that the launch of its Phas...ve sites across North and South America.,These tr...nal Institutes of,Health (NIH), and the HIV Vacci...
(Date:11/30/2008).../ -- Abnormalities in auditory and language proces...trum disorder by using magnetoencephalography (MEG...ual meeting of the Radiological Society of North A...d the tiny magnetic fields associated with electri...vice chair of research in the Department of Radiol...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3SemBioSys eligible to proceed with Phase I II plant produced insulin trial after submission of IND 7709 1SemBioSys eligible to proceed with Phase I II plant produced insulin trial after submission of IND 7709 2SemBioSys eligible to proceed with Phase I II plant produced insulin trial after submission of IND 7709 3Intact Medical Corporations Intact 28R 29 Excise XL Receives 510 28K 29 Marketing Clearance from the FDA 7708 1Intact Medical Corporations Intact 28R 29 Excise XL Receives 510 28K 29 Marketing Clearance from the FDA 7708 2BioCryst to Present at UBS 2008 Global Life Sciences Conference 7703 1BioCryst to Present at UBS 2008 Global Life Sciences Conference 7703 2BioCryst to Present at UBS 2008 Global Life Sciences Conference 7703 3Althea Technologies Secures 2412 M Credit Line to Continue Facility Growth and Expansion 7701 1Althea Technologies Secures 2412 M Credit Line to Continue Facility Growth and Expansion 7701 2..., 4th May 2007 - CeNeS Pharmaceuticals plc,(LSE: C..., notes,the publication of an independent study in...s Phase II NMDA antagonist, CNS 5161. CeNeS,is dev...opathic,pain. The independent study builds on the ...61. , In the study reported in ,Synapse, Dr Anat ...
...BUSINESS WIRE)--May 4, 2007 - New data from a,rand...on of,COPAXONE(R) (glatiramer acetate injection) a...T1 Gadolinium (Gd)-enhancing lesions,of the brain ...apsing-remitting multiple sclerosis (RRMS), as mea...d to those receiving,COPAXONE(R) alone. Additional...
Other Medicine Technology:Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 2Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5